Albert Khilevich
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Carbohydrate Chemistry and Synthesis, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, HIV/AIDS drug development and treatment, Traditional and Medicinal Uses of Annonaceae
Most-Cited Works
- → Synthesis, Chromatographic Resolution, and Anti-Human Immunodeficiency Virus Activity of (±)-Calanolide A and Its Enantiomers(1996)214 cited
- → N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a Novel Metabotropic Glutamate 2 Potentiator with Potential Anxiolytic/Antidepressant Properties: In Vivo Profiling Suggests a Link between Behavioral and Central Nervous System Neurochemical Changes(2010)99 cited
- → Structural Analogues of the Calanolide Anti-HIV Agents. Modification of the trans-10,11-Dimethyldihydropyran-12-ol Ring (Ring C)(1997)69 cited
- → Discovery of the First α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist Dependent upon Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8(2016)58 cited
- → In vivo anti-HIV activity of (+)-calanolide a in the hollow fiber mouse model(1999)57 cited
- → In vitro anti-human immunodeficiency virus (HIV) activity of the chromanone derivative, 12-oxocalanolide A, a novel NNRTI(1998)44 cited
- → Synthesis of pyrazoles and isoxazoles as potent αvβ3 receptor antagonists(2006)39 cited
- → Synthesis of (+)-calanolide A, an anti-HIV agent, Via enzyme-catalyzed resolution of the aldol products(1996)34 cited
- → Activation of metabotropic glutamate (mGlu)2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge(2009)33 cited
- → Novel approach for synthesis of (±)-calanolide a and its anti-HIV activity(1995)28 cited